Elektrofi is a biotechnology company focused on improving administration for a wide range of medicines including monoclonal antibodies, therapeutic proteins, and other large molecule drugs. Its breakthrough formulation platform enables stabilized, highly concentrated formulations for subcutaneous administration. The company is using this technology to transform therapies that are administered intravenously, and to enhance injectable products by reducing the volume and frequency of dosing. Elektrofi partners with pharmaceutical companies to jointly develop patient-friendly delivery solutions. Headquartered in Boston, the company’s founding team of MIT engineers and scientists are shaping the future of biologics delivery.
Elektrofi Address
451 D street Boston, MA United States
Elektrofi Email
Past Companies
ElektrofiHead of Science
Evelo BiosciencesScientific Strategy and Corporate Development Fellow
MITNSF Graduate Research Fellow (Prof. Rudolf Jaenisch)